+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Pharmaceuticals Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 4871549
  • Report
  • October 2020
  • Region: Global
  • 200 pages
  • The Business Research Company
UP TO OFF
until Dec 31st 2020
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aratana Therapeutics Inc.
  • Boehringer Ingelheim GmbH
  • Elanco US Inc
  • Norbrook Laboratories Ltd
  • Provetica AH LLC
  • Vetoquinol
  • MORE
Veterinary Pharmaceuticals Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the veterinary pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Veterinary Pharmaceuticals Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive land scape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive land scape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:
1) By Type: Veterinary Vaccines; Veterinary Antibiotics; Veterinary Parasiticides; Others
2) By End User: Veterinary Hospitals; Veterinary Clinics; Pharmacies and Drug stores
3) By Route of Administration: Oral; Others (Parental; Topical)
4) By Animal Type: Companion Animals; Livestock Animals
5) By Vaccines: Inactivated vaccines; Attenuated vaccines; Recombinant vaccines

Companies Mentioned: Merck & Co. Inc; Zoetis Inc.; Eli Lilly and Company; Bayer AG; Boehringer Ingelheim GmbH

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Aratana Therapeutics Inc.
  • Boehringer Ingelheim GmbH
  • Elanco US Inc
  • Norbrook Laboratories Ltd
  • Provetica AH LLC
  • Vetoquinol
  • MORE
1. Executive Summary

2. Veterinary Pharmaceuticals Market Characteristics

3. Veterinary Pharmaceuticals Market Size And Growth
3.1. Global Veterinary Pharmaceuticals Historic Market, 2015-2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Veterinary Pharmaceuticals Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Veterinary Pharmaceuticals Market Segmentation
4.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Veterinary Vaccines
  • Veterinary Antibiotics
  • Veterinary Parasiticides
  • Others
4.2. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug stores
4.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Others (Parental, Topical)
4.4. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Companion Animals
  • Livestock Animals
4.5. Global Veterinary Pharmaceuticals Market, Segmentation By Vaccines, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Inactivated vaccines
  • Attenuated vaccines
  • Recombinant vaccines
5. Veterinary Pharmaceuticals Market Regional And Country Analysis
5.1. Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Veterinary Pharmaceuticals Market
6.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
6.2. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Veterinary Pharmaceuticals Market
7.1. China Veterinary Pharmaceuticals Market Overview
7.2. China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Veterinary Pharmaceuticals Market
8.1. India Veterinary Pharmaceuticals Market Overview
8.2. India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Veterinary Pharmaceuticals Market
9.1. Japan Veterinary Pharmaceuticals Market Overview
9.2. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Veterinary Pharmaceuticals Market
10.1. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Veterinary Pharmaceuticals Market
11.1. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Veterinary Pharmaceuticals Market
12.1. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Veterinary Pharmaceuticals Market
13.1. Western Europe Veterinary Pharmaceuticals Market Overview
13.2. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Veterinary Pharmaceuticals Market
14.1. UK Veterinary Pharmaceuticals Market Overview
14.2. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Veterinary Pharmaceuticals Market
15.1. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Veterinary Pharmaceuticals Market
16.4. France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Veterinary Pharmaceuticals Market
17.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
17.2. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Veterinary Pharmaceuticals Market
18.1. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Veterinary Pharmaceuticals Market
19.1. North America Veterinary Pharmaceuticals Market Overview
19.2. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Veterinary Pharmaceuticals Market
20.1. USA Veterinary Pharmaceuticals Market Overview
20.2. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Veterinary Pharmaceuticals Market
21.1. South America Veterinary Pharmaceuticals Market Overview
21.2. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Veterinary Pharmaceuticals Market
22.1. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Veterinary Pharmaceuticals Market
23.1. Middle East Veterinary Pharmaceuticals Market Overview
23.2. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Veterinary Pharmaceuticals Market
24.1. Africa Veterinary Pharmaceuticals Market Overview
24.2. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Veterinary Pharmaceuticals Market Competitive Landscape And Company Profiles
25.1. Veterinary Pharmaceuticals Market Competitive Landscape
25.2. Veterinary Pharmaceuticals Market Company Profiles
25.2.1. Merck & Co. Inc
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Zoetis Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Eli Lilly and Company
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Bayer AG
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Boehringer Ingelheim GmbH
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

27. Veterinary Pharmaceuticals Market Trends And Strategies

28. Veterinary Pharmaceuticals Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Aratana Therapeutics Inc.
  • Boehringer Ingelheim GmbH
  • Elanco US Inc
  • Norbrook Laboratories Ltd
  • Provetica AH LLC
  • Vetoquinol
  • MORE
The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals and related services. This industry includes establishments that produce veterinary medicines which are used for pet animals and farm animals (includes vaccines, antibiotics and parasiticides).

The global veterinary pharmaceuticals market is expected to decline from $14.8 billion in 2019 to $13.1 billion in 2020 at a compound annual growth rate (CAGR) of -11.6%. The decline is mainly due to the COVID-19 outbreak and the measures to contain it. COVID-19 pandemic is affecting industries across the globe including the animal sector. The restrictions on non-essential medical services coupled with slowed production of veterinary pharmaceuticals due to extended factory closures in various countries, shortage of APIs and other chemicals, and rise in prices of key ingredients are the key factors for this decline. The market is then expected to recover and grow at a CAGR of 7.5% from 2021 and reach $19.7 billion in 2023.

North America was the largest region in the veterinary pharmaceuticals market in 2016, accounting for about 32% of the share in the market.

Increase in the prevalence rate of diseases among animals serves as one of the major drivers for the veterinary pharmaceuticals market. Increase in the incidence of diseases in livestock and companion animals will require medicines to treat animals for the disease. For instance, according to Banfield State of Pet Health report 2016, the prevalence of diabetes in dogs has increased by 79.7% from 13.1 cases per 10,000 in 2006 to 23.6 cases in 2015 whereas the prevalence rate increased by 18% in cats from 2006 to 2015. The increase in prevalence rate of diseases among animals results in increased demand for veterinary pharmaceuticals.

The veterinary pharmaceuticals market is being restrained by lack of awareness about animal healthcare. According to the Animal Welfare Act 2006 a proper healthcare means the pet should have the regular vaccination, a suitable diet, protection from pain, suffering and should be free from any kind of disease. According to the latest PDSA Animal Wellbeing (PAW) UK report 2018, only 38% people in the UK are aware of this legislation which shows a very less proportion of the population is aware of the animal healthcare and acts as a major restraint for the market.

The rise in generic drugs for animal care is being seen as the latest trend in the veterinary pharmaceuticals market. The economical nature of generic drugs is enabling the pet lovers to take care of their pets efficiently. During 2013-2015, FDA has approved 22 generic animal drugs for cats and dogs which has increased the adoption of generic drugs by the veterinarians. According to a survey conducted on 520 veterinarians by Brakke and Trone Brand Energy Inc., around 80% of the veterinarians confirmed that they are using generic drugs in order to save the pet owners’ money. However, the lower margin of profit given by generic drug manufacturers compared with heavy margins of branded drugs needs to be looked in by the veterinarians.

The veterinary pharmaceuticals market is regulated by government agencies such as European Medicines Agency (EMA), USFDA (the US food and drug ministration), and others. For instance, the EU agencies require 6 to 12 months to approve the veterinary medicinal products. Moreover, it requires all parts of the registration dossier to be submitted together unlike the US-FDA which accepts phased submissions. The US-FDA assesses each technical section for 6 months which may increase to another 6 months’ cycle if questions/concerns are raised. However, the technical sections’ assessment is done simultaneously and therefore the manufacturers should identify the time taking steps and plan the work accordingly and estimate date of approval. Also, the license validity and renewal of the application in EU region is very difficult upon the existing regulatory policies. Therefore, the manufacturers of veterinary pharmaceuticals should plan well, communicate effectively in order to minimize the costs and reduce timelines.

Major players in the market are Merck & Co. Inc., Zoetis Inc., Eli Lilly and Company, Bayer AG, Boehringer Ingelheim GmbH
Note: Product cover images may vary from those shown
4 of 5
  • Merck & Co. Inc
  • Zoetis Inc.
  • Eli Lilly and Company
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Perrigo Company plc
  • Virbac SA
  • Dechra Pharmaceuticals plc
  • Ceva Sante Animale
  • Aratana Therapeutics Inc.
  • Vetoquinol
  • Ceva Santé Animale
  • Virbac SA
  • Pegasus Laboratories Inc
  • Provetica AH LLC
  • Norbrook Laboratories Ltd
  • Putney Inc.
  • Elanco US Inc
  • Phibro Animal Health Corp.
  • Bimeda Animal Health Ltd.
  • Syndel USA
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll